Gland Pharma Shares Jump 5% After US FDA Inspection at JNPC Facility
Shares of Gland Pharma rose 5% on February 25, marking their best performance in 16 weeks. The surge came ahead of the company’s investor meet on February 27-28, which will be attended by analysts from Emkay and BoB Capital. The rise in share price follows the United States Food and Drug Administration (US FDA) pre-approval […]
Gland Pharma Shares Jump 5% After US FDA Inspection at JNPC Facility Read More »









